TY  - GEN
AU  - Zhang,Fu-quan
AU  - Yang,Wen-tao
AU  - Duan,Shan-zhou
AU  - Xia,Ying-chen
AU  - Zhu,Rong-ying
AU  - Chen,Yong-bing
TI  - JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor
SN  - 1949-2553
PY  - 2016///0512
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Proliferation
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - ErbB Receptors
KW  - genetics
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Humans
KW  - Janus Kinase 2
KW  - antagonists & inhibitors
KW  - Lung Neoplasms
KW  - Mice
KW  - Mice, Nude
KW  - Pyrrolidines
KW  - Sulfonamides
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.3685
ER  -